Skip to main content
. 2020 Jun 26;11:593. doi: 10.3389/fneur.2020.00593

Figure 3.

Figure 3

Proportion of individuals, by genotype, who had ever trialed an antimyotonia medication and who were currently taking one at the time of chart review.